in septic patients: Clinical and metabolic aspects. Crit Care Med25:418–424, 1997
2.
39. Brennan MF, Cerra FB, Daly JM, et al. Report of a research workshop: Branched-chain amino acids in stress and injury. JPEN10:446–452, 1982
3.
40. Cerra FB, Mazuski J, Teasley K, et al. Nitrogen retention in critically ill patients is proportional to the branched chain amino acid load. Crit Care Med11:775–778, 1983
4.
41. Cerra FB, Mazuski JE, Chuter E, et al. Branched chain metabolic support: A prospective, randomized, double-blind trail in surgical stress. Ann Surg199: 286–291, 1984
5.
42. Okada A, Mori S, Totsuka M, et al. Branched-chain amino acid metabolic support in surgical patients: A randomized controlled trial in patients with subtotal or total gastrectomy in 16 Japanese institutions. JPEN12:332–337, 1988
6.
43. Brown RO, Buonpane EA, Vehe KL, et al. Comparison of modified amino acids and standard amino acids in parenteral nutrition support of thermally injured patients. Crit Care Med18:1096–1101, 1990
7.
44. Van Way CW, Moore EE, Alio M, et al. Comparison of TPN with 25 percent and 45 percent branched chain amino acids in stressed patients. Am Surg51:609–616, 1985
8.
45. Vaner Woude P, Morgan RE, Kosta JM, et al. Addition of branched-chain amino acids to parenteral nutrition of stressed critically ill patients. Crit Care Med14:685–688, 1986
9.
46. Von Meyenfeldt MF, Soeters PB, Vente JP, et al. Effect of branched chain amino acid enrichment of TPN on nitrogen sparing and clinical outcome of sepsis and trauma: A prospective randomized double blind trial. Br J Surg77:924–929, 1990
10.
47. Skeie B, Kvetan V, Gil KM, et al. Branch-chain amino acids: Their metabolism and clinical utility. Crit Care Med18:549–571, 1990
11.
48. Lenssen P, Cheney CL, Aker S, et al. Intravenous branched chain amino acids in marrow transplant patients. JPEN11:112–118, 1987
12.
49. Vente JP, Soeters PB, Von Meyenfeldt MF, et al. Prospective randomized double-blinded trial of branched-chain amino acid enriched versus standard parenteral nutrition solutions in traumatized and septic patients. World J Surg15:128–132, 1991
13.
50. Melnick G.Value of specialty intravenous amino acid solutions. Am J Health Syst Pharm53:671–674, 1996
14.
51. Bower RH, Muggia-Sullam M, Hurst JM, et al. Branched chain amino acid-enriched solutions in the septic patient: A randomized prospective trial. Ann Surg203:13–20, 1986
15.
52. Bruzzone P, Siegel JH, Chiarla C, et al. Leucine dose response in reduction of urea production from septic proteolysis and in the stimulation of acute-phase proteins. Surgery109:768–778, 1991
51. Cao Y, Feng I, Hoos A, et al. Glutamine enhances gut glutathione production. JPEN22: 224–227, 1998
18.
55. Elia M, Folmer P, Schlatman A, et al. Amino acid metabolism in muscle and in the whole body of man before and after ingestion of a single mixed meal. Am J Clin Nutr49:1203–1210, 1989
19.
56. Ardawi MSM, Newsholme EA.Glutamine metabolism in lymphocytes of the rat. J Biochem212:835–842, 1983
20.
57. Van der Hulst RR, van Kreel BK, Von Meyenfeldt MF, et al. Glutamine and the preservation of gut integrity. Lancet34:1363–1365, 1993
21.
58. Ziegler TR, Benfell K, Smith RJ, et al. Safety and metabolic effects of L-glutamine administration in humans. JPEN14(Suppl):137S–146S, 1990
22.
59. Bart JM, Stehle P, Wachter P, et al. TPN with glutamine dipeptide after major abdominal surgery. Ann Surg227:302–308, 1998
23.
60. Zeigler TR, Young LS, Benfell K, et al. Clinical and metabolic efficacy of glutamine-supplemented parenteral nutrition after bone marrow transplantation. A randomized, double-blind, controlled study. Ann Intern Med116:821–828, 1992
24.
61. Hornsby-Lewis L, Shike M, Brown P, et al. L-Glutamine supplementation in home TPN patients: Stability, safety, and effects on intestinal absorption. JPEN18:268–273, 1994
25.
62. Morlion BJ, Stehle P, Wachtler P, et al. TPN with glutamine-dipeptide after major abdominal surgery: A randomized, double-blind, controlled trial. Ann Surg227:302, 1998
26.
63. Schloerb PR, Amare M.'TPN with glutamine in bone marrow' transplantation and other clinical applications (a randomized, double-blind study). JPEN17:407–413, 1993
27.
64. Byrne TA, Morrissey TB, Nattakom TV, et al. Growth hormone, glutamine and a modified diet enhance nutrient absorption in patients with severe short bowel syndrome. JPEN19:296–302, 1995
28.
65. Szkudlarek J, Jeppesen PB, Mortenscn PB.Effect of high-dose growth hormone with glutamine and no change in diet on intestinal absorption in short bowel patients: A randomized, double blind, crossover, placebo controlled study. Gut47:199–205, 2000
29.
66. Scolapio JS.Effect of growth hormone and glutamine on short bowel. Five years later (commentaries) Gut47:164–5, 2000
30.
67. Lipp J.Glutamine and immune function: Theory and clinical applications. Support Line19:14–18, 1997